NEWS BRIEFS
THE COLUMBUS DISPATCH
WASHINGTON
Two weight-loss drugs must add label warnings
The Food and Drug Administration said yesterday that it’s ordering a revision of the labels of the weight-loss drugs Xenical and Alli to warn of the risk of very rare cases of severe liver damage associated with their use.
The agency said it had identified 13 cases of severe liver damage associated with the drugs: one in the United States and 12 abroad. Two of the patients died of liver failure, and three others required liver transplants. The FDA said it could not positively say that the drug caused the damage because there was insufficient data in most of the cases.
Advertisement